StockNews.AI
SINA
StockNews.AI
49 days

ZAP Surgical Systems and Ibn Sina Medical Center to Bring Groundbreaking Non-Invasive Brain Surgery Platform to Africa

1. Ibn Sina Medical Center introduces the ZAP-X system in Morocco. 2. Installation of the ZAP-X is set for summer 2025. 3. ZAP-X enhances precision in brain tumor treatment with innovative targeting. 4. Self-shielded design reduces costs for hospitals acquiring new technology. 5. ZAP Surgical aims to improve access to advanced surgical options.

6m saved
Insight
Article

FAQ

Why Neutral?

While the article discusses innovation in healthcare, it does not directly affect SINA's immediate market situation or stock performance. Historical examples show that new medical technology announcements can impact related firms, but the specifics of competition and market conditions must be considered.

How important is it?

Although the article presents significant developments in medical technology, the direct implications for SINA remain unclear, leading to a moderate importance score.

Why Long Term?

The adoption of new medical technologies like ZAP-X typically influences the market over a longer term as the technology needs time for validation, integration, and widespread acceptance.

Related Companies

SINAZAPACRXARAY
- SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Ibn Sina Medical Center will become the first hospital in Morocco, and the first in Africa, to introduce the cutting-edge ZAP-X® Gyroscopic Radiosurgery® platform. This innovative non-invasive surgical robotics system is poised to transform brain cancer treatment across the region. Located in Casablanca, Ibn Sina Medical Center is a state-of-the-art facility currently under construction. The ZAP-X installation is scheduled to begin the summer of 2025, with the first patient treatments planned for fall of 2025. Stereotactic radiosurgery (SRS) is a completely non-invasive and painless outpatient procedure that has revolutionized the treatment of many primary and metastatic brain tumors, as well as other conditions affecting the brain, head, and neck. Typically completed in a single brief outpatient visit, SRS allows patients to often resume normal activities on the same day as treatment. Dr. Faouzi L’ Habeeb, radiation and medical oncologist, managing partner and chairman at Ibn Sina Medical Center, commented, “The ZAP-X platform signifies the future of brain tumor treatment, allowing us to improve patients' quality of life both throughout and following their treatment.” A primary motivation behind Ibn Sina Medical Center’s acquisition of the ZAP-X system is its self-contained, self-shielded design. This unique feature eliminates the requirement for hospitals to build expensive, shielded radiation vaults. “ZAP Surgical's mission is to make world-class stereotactic radiosurgery accessible to the millions of patients who currently lack access,” commented John R. Adler, MD, Professor Emeritus of Neurosurgery at Stanford University and Founder and CEO of ZAP Surgical Systems. “By reducing the costs and complexities of traditional SRS delivery, ZAP aims to support providers such as Ibn Sina Medical Center and others around the globe with best-in-class care.” The ZAP-X system is also renowned for its innovative gyroscopic targeting, enabling radiosurgical beams to be delivered from thousands of potential angles. This pioneering approach enhances precision by hyper-focusing radiation to intracranial lesions while also minimizing radiation exposure to healthy brain tissue, thus helping to preserve patient cognitive function. Additionally, ZAP-X is the first and only dedicated cranial radiosurgery platform to eliminate the need for Cobalt-60 radioactive isotopes. Instead, it employs a modern linear accelerator to generate radiation, removing the costs and logistical challenges associated with acquiring, securing, and regularly replacing potentially dangerous radioactive materials. “The entire ZAP team is honored to work alongside Dr. L’ Habeeb and the clinical team at Ibn Sina Medical Center,” said Ahmed Salem, Regional Business Director for ZAP Surgical. “With the addition of ZAP-X, they continue a proud tradition of bringing the latest and most advanced radiation delivery technologies to Morocco.” The successful introduction of this cutting-edge technology to Morocco was spearheaded by Issam Fadil and Faisal Khalil Jouhari of Promedstore Imaging, the official regional distributor of ZAP-X. For more information about ZAP-X, please visit www.zapsurgical.com. About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler, Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn. More News From ZAP Surgical Systems, Inc.

Related News